Overview

The Gynaecologic oncology department offers an integrated approach to the diagnosis and surgical management of women's cancers of the reproductive system. These include cervical cancer, ovarian cancer (includes fallopian tube and peritoneal) , pelvic masses, uterine cancer, vaginal cancer and vulvar cancer of the female reproductive system.


Gynaecological cancers have increased in India and are estimated to be around 200,000 per year and constitutes about 30% of the total cancers among women in India. Ovarian and cervical cancers are the most common gynaecological cancers affecting women worldwide and in India.


Cervical cancer is on a declining trend but remains the second most common cancer in women after breast cancer.

Why APCC for Gynaecological Oncology?

We are one of the best cancer care providers in the continent and a tertiary referral centre. We have nationally and internationally recognized doctors treating you, and are up to date with current evidence and research. Our team offers you comprehensive care with compassion, clinical excellence and with a multi-disciplinary team (MDT) including gynaecologic oncologists, radiation oncologists, medical oncologists, surgeons of other specialties, specialist nurses, radiologists, pathologist and other supportive services. We treat vulval, vaginal, cervical, uterine and ovarian cancer. We can assure you that we support you in all aspects during and after your treatment and give you the best possible care. We are a specialist center in treating advanced ovarian cancers and recurrent cancers.

Types of Gynaecological Cancers


Winning over Cancer with Apollo Proton Cancer Centre

The growing burden of cancer across the globe tells an ominous tale. To counter this growing threat, Apollo Hospitals introduces Proton Beam therapy with focused cancer management teams that will provide optimal solutions like never before. We believe it is critical to redefine our purpose, to reboot our commitment on the single-minded focus to win over cancer. APCC stands as a ray of hope for millions of patients as they join us in the battle to win over cancer.